Health Trials

Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience

ConditionsInfusions, IntravenousAdministration, IntravenousHome Infusion TherapyParenteral Nutrition, HomeCentral Venous CathetersCatheterization, Central VenousCatheterization, PeripheralVascular Access DevicesPatient Education as TopicPatient ParticipationUser-Computer InterfaceSmartphoneMobile ApplicationsComputers, HandheldDigital HealthNursingCare GiversDelivery of Health CareHome NursingSelf AdministrationAdverse EffectsCatheter-Related InfectionsTelemedicine
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFundacion Miguel Servet

About this trial

The study focuses on patients who require outpatient infusion of therapy ("Infusions, Intravenous"\[Mesh\]) "Administration, Intravenous"\[Mesh\] ("Home Infusion Therapy"\[Mesh\]) "Parenteral Nutrition, Home"\[Mesh\] via a peripherally inserted central catheter (PICC) ("Central Venous Catheters"\[MeSH\] "Catheterization, Central Venous"\[MeSH\] "Catheterization, Peripheral" \[MeSH\] "Vascular Access Devices"\[Mesh\] )

Eligibility criteria

Qualifiers

Patients >18 years.

Sign the informed consent form.

Have a Smartphone and accept the use of the APP.

Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month.

Disqualifiers

Patients with limitations in the use of digital resources or lack of Smartphone.

Patients who do not want to install the APP on their Smartphone

Patients who do not authorize access to their Computerized Medical Record (HCI).

Trial design

Treatments tested in this trial

  • Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters

Treatment groups

201 Participants
are divided into 2 treatment groups

Locations

1
Hospital Universitario de Navarra31003, PamplonaNavarre, Spain

Sponsors and collaborators

Fundacion Miguel Servet

Lead sponsor

Universidad Pública de Navarra

Collaborator

Source ClinicalTrials.gov